These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3767121)

  • 21. Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests: a prospective study.
    Sakuma K; Takahara T; Okuda K; Tsuda F; Mayumi M
    Gastroenterology; 1982 Jul; 83(1 Pt 1):114-7. PubMed ID: 7075936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
    Hopkirk N; Moyes CD; Lucas CR
    N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoniazid hepatitis in adolescents.
    Litt IF; Cohen MI; McNamara H
    J Pediatr; 1976 Jul; 89(1):133-5. PubMed ID: 819639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical use of liver biopsy for the diagnosis and management of inactive and asymptomatic hepatitis B virus carriers in Bangladesh.
    Al-Mahtab M; Rahman S; Akbar SM; Kamal M; Khan MS
    J Med Virol; 2010 Aug; 82(8):1350-4. PubMed ID: 20572087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
    Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.
    Yim SY; Um SH; Jung JY; Seo YS; Yim HJ; Ryu HS; Chun HJ; Jeen YT; Kim CD; Keum B; Lee HS
    J Clin Gastroenterol; 2014 Feb; 48(2):166-71. PubMed ID: 24045280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state.
    Feinman SV; Berris B; Cooter N; Sinclair JC; Wrobel DM
    Hepatogastroenterology; 1982 Apr; 29(2):58-61. PubMed ID: 7084885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoniazid hepatotoxicity among drug users: the role of hepatitis C.
    Fernández-Villar A; Sopeña B; Vázquez R; Ulloa F; Fluiters E; Mosteiro M; Martínez-Vázquez C; Piñeiro L
    Clin Infect Dis; 2003 Feb; 36(3):293-8. PubMed ID: 12539070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.
    Mahoney FJ; Lawrence M; Scott C; Le Q; Lambert S; Farley TA
    Pediatrics; 1995 Dec; 96(6):1113-6. PubMed ID: 7491231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey.
    Yalcin K; Degertekin H; Bahcecioglu IH; Demir A; Aladag M; Yildirim B; Horasanli S; Ciftci S; Badur S
    Infection; 2004 Feb; 32(1):24-9. PubMed ID: 15007739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
    J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hepatitis B carrier state.
    Murray BJ
    Am Fam Physician; 1986 Apr; 33(4):127-33. PubMed ID: 2938461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B follow-up among Indochinese refugees.
    Nicholls ES; Chaudhary RK; Kennedy DA; Jung J; Davies JW; Gill P
    Can Med Assoc J; 1984 Nov; 131(9):1073-6. PubMed ID: 6498718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of hepatitis B surface antigen (HBsAg) in patients with pulmonary tuberculosis].
    Fondaminskaia LD
    Probl Tuberk; 1986; (3):25-7. PubMed ID: 3714688
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepatitis B infections in families of carriers].
    Gastmeier P; Güthoff W
    Offentl Gesundheitswes; 1991 Jul; 53(7):325-7. PubMed ID: 1833704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral load in hepatitis B e antigen-negative carriers with normal aminotransferase level.
    Liaw YF
    Hepatology; 2007 Sep; 46(3):947; author reply 947-9. PubMed ID: 17705263
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis B virus infection among children born in the United States to Southeast Asian refugees.
    Franks AL; Berg CJ; Kane MA; Browne BB; Sikes RK; Elsea WR; Burton AH
    N Engl J Med; 1989 Nov; 321(19):1301-5. PubMed ID: 2797103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical aspects and treatment of destructive pulmonary tuberculosis in patients, carriers of hepatitis B virus].
    Shtefanaru LK
    Probl Tuberk; 1986; (7):40-3. PubMed ID: 3763588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.